Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CollaRx Bupivacaine Implant for pain control after abdominal hysterectomy
2008-001719-39Phase 2Terminated
- Sponsor
- Innocoll
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of XARACOLL in postoperative pain (2 arms), sponsored by Innocoll. Primary endpoints: narcotic-sparing effect, efficacy parameters of bupivacaine and 1 more. Started May 2008; status: terminated.
02
Drugs
XARACOLL
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2008-001719-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001719-39.